JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Bovine serum albumin-Camptothecin nanoparticles for RNAs packaging to improve the prognosis of Cancer

  • 0Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education & international Joint Research Center of Human-machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province & Hainan Provincial Key Laboratory of Research and Development on Tropical Herbs, School of Pharmacy, Hainan Medical University, Haikou, Hainan 571199, PR China.
International Journal of Biological Macromolecules +

|

October 30, 2024

|

October 30, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study developed bovine serum albumin (BSA) nanoparticles with Camptothecin (CPT) to enhance cancer drug delivery. These RNA-packaged nanoparticles effectively target cancer cells and inhibit their growth, showing promise for improved cancer therapy.

Area Of Science

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapeutics

Background

  • RNA therapeutics show promise for targeted cancer treatment.
  • Improving drug bioavailability and targeting remains a challenge in cancer therapy.
  • Bovine serum albumin (BSA) nanoparticles offer a biocompatible platform for drug delivery.

Purpose Of The Study

  • To construct and optimize bovine serum albumin-Camptothecin nanoparticles (BSA-CPT-NPs) for enhanced drug delivery.
  • To evaluate the in vitro efficacy of BSA-CPT-NPs in targeting cancer cells and regulating xRNA expression.
  • To assess the potential of RNA-packaged nanoparticles for improving cancer patient prognosis.

Main Methods

  • Synthesis of BSA-CPT-NPs using the phacoemulsification method.
  • Optimization of nanoparticle synthesis using a single-factor orthogonal design.
  • In vitro evaluation of nanoparticle cytotoxicity, drug loading, RNA encapsulation efficiency, and effects on intracellular RNA expression.

Main Results

  • Uniform BSA-CPT-NPs were successfully synthesized with high drug loading and RNA encapsulation efficiency.
  • The nanoparticles demonstrated significant inhibition of cancer cell proliferation in vitro.
  • BSA-CPT-NPs effectively modulated intracellular RNA expression, enhancing anti-tumor effects.

Conclusions

  • BSA-CPT nanoparticles packaged by RNA show potential for improving drug delivery efficiency and targeting in cancer therapy.
  • These nanoparticles offer a promising strategy for enhancing anti-tumor effects by regulating xRNA expression.
  • Further research is warranted to explore the clinical feasibility of RNA-packaged BSA-CPT nanoparticles for cancer treatment.

Keywords: